Search

Author/Creator Hess‐Stumpp, Holger

1. BAY 87‐2243, a highly potent and selective inhibitor of hypoxia‐induced gene activation has antitumor activities by inhibition of mitochondrial complex I. (20th August 2013)

Authors:
Ellinghaus, Peter; Heisler, Iring; Unterschemmann, Kerstin; Haerter, Michael; Beck, Hartmut; Greschat, Susanne; Ehrmann, Alexander; Summer, Holger; Flamme, Ingo; Oehme, Felix; Thierauch, Karlheinz; Michels, Martin; Hess‐Stumpp, Holger; Ziegelbauer, Karl
Journal:
Cancer medicine
Issue:
Volume 2:Number 5(2013:Oct.)
Page Start:
611
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Inhibition of Hypoxia‐Induced Gene Transcription by Substituted Pyrazolyl Oxadiazoles: Initial Lead Generation and Structure–Activity Relationships. Issue 1 (27th November 2013)

Authors:
Härter, Michael; Thierauch, Karl‐Heinz; Boyer, Stephen; Bhargava, Ajay; Ellinghaus, Peter; Beck, Hartmut; Greschat‐Schade, Susanne; Hess‐Stumpp, Holger; Unterschemmann, Kerstin
Journal:
ChemMedChem
Issue:
Volume 9:Issue 1(2014:Jan.)
Page Start:
61
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Rogaratinib: A potent and selective pan‐FGFR inhibitor with broad antitumor activity in FGFR‐overexpressing preclinical cancer models. Issue 5 (13th March 2019)

Authors:
Grünewald, Sylvia; Politz, Oliver; Bender, Sebastian; Héroult, Mélanie; Lustig, Klemens; Thuss, Uwe; Kneip, Christoph; Kopitz, Charlotte; Zopf, Dieter; Collin, Marie‐Pierre; Boemer, Ulf; Ince, Stuart; Ellinghaus, Peter; Mumberg, Dominik; Hess‐Stumpp, Holger; Ziegelbauer, Karl
Journal:
International journal of cancer
Issue:
Volume 145:Issue 5(2019)
Page Start:
1346
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗